152 related articles for article (PubMed ID: 38221817)
1. Non-Contrast Abbreviated Magnetic Resonance Imaging: A Cost-Effective Rookie in Hepatocellular Carcinoma Surveillance for Cirrhotic Patients.
Heo S; Choi WM
Gut Liver; 2024 Jan; 18(1):7-9. PubMed ID: 38221817
[No Abstract] [Full Text] [Related]
2. Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis.
Decharatanachart P; Pan-Ngum W; Peeraphatdit T; Tanpowpong N; Tangkijvanich P; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
Gut Liver; 2024 Jan; 18(1):135-146. PubMed ID: 37560799
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules.
Jeong YY; Yim NY; Kang HK
AJR Am J Roentgenol; 2005 Oct; 185(4):1024-32. PubMed ID: 16177427
[TBL] [Abstract][Full Text] [Related]
4. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
[TBL] [Abstract][Full Text] [Related]
6. The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis.
Dănilă M; Sporea I; Sirli R; Popescu A; Sendroiu M; Martie A
Med Ultrason; 2010 Jun; 12(2):145-9. PubMed ID: 21173943
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis.
Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
Dig Liver Dis; 2015 Sep; 47(9):775-82. PubMed ID: 26043653
[TBL] [Abstract][Full Text] [Related]
8. Effect of increasing the flip angle during the hepatocyte phase of gadobenate dimeglumine-enhanced 1.5T MRI in cirrhotic patients with hepatocellular carcinoma.
Lee EJ; Kim DJ; Cho ES; Kim KA
J Magn Reson Imaging; 2016 Mar; 43(3):713-9. PubMed ID: 26290384
[TBL] [Abstract][Full Text] [Related]
9. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
10. Imaging of dysplastic nodules and small hepatocellular carcinomas: experience with explanted livers.
Krinsky G
Intervirology; 2004; 47(3-5):191-8. PubMed ID: 15383729
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
[TBL] [Abstract][Full Text] [Related]
12. How to differentiate liver lesions in cirrhosis.
Bartolozzi C; Crocetti L; Della Pina MC
JBR-BTR; 2007; 90(6):475-81. PubMed ID: 18376759
[TBL] [Abstract][Full Text] [Related]
13. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma in cirrhosis: semeiology and performance of magnetic resonance imaging and lipiodol computed tomography].
Marcato N; Abergel A; Alexandre M; Boire JY; Darcha C; Duchène B; Chipponi J; Boyer L; Viallet JF; Bommelaer G
Gastroenterol Clin Biol; 1999 Jan; 23(1):114-21. PubMed ID: 10219612
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular nodules in liver cirrhosis: MR evaluation.
Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
[TBL] [Abstract][Full Text] [Related]
16. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
[TBL] [Abstract][Full Text] [Related]
17. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.
Cereser L; Furlan A; Bagatto D; Girometti R; Como G; Avellini C; Orsaria M; Zuiani C; Bazzocchi M
J Comput Assist Tomogr; 2010; 34(5):706-11. PubMed ID: 20861773
[TBL] [Abstract][Full Text] [Related]
18. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
[TBL] [Abstract][Full Text] [Related]
20. Double-contrast MRI in patients with cirrhosis.
Guiu B; Loffroy R; Cercueil JP
AJR Am J Roentgenol; 2008 Aug; 191(2):W78. PubMed ID: 18647893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
